Ingelman-Sundberg M - Search Results

1

S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians.

Persson I, Aklillu E, Rodrigues F, Bertilsson L, Ingelman-Sundberg M. Persson I, et al. Pharmacogenetics. 1996 Dec;6(6):521-6. doi: 10.1097/00008571-199612000-00005. Pharmacogenetics. 1996. PMID: 9014201

2

Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden.

Aklillu E, Herrlin K, Gustafsson LL, Bertilsson L, Ingelman-Sundberg M. Aklillu E, et al. Pharmacogenetics. 2002 Jul;12(5):375-83. doi: 10.1097/00008571-200207000-00005. Pharmacogenetics. 2002. PMID: 12142727

3

Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.

Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. Aklillu E, et al. J Pharmacol Exp Ther. 1996 Jul;278(1):441-6. J Pharmacol Exp Ther. 1996. PMID: 8764380

4

Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population.

Roh HK, Dahl ML, Johansson I, Ingelman-Sundberg M, Cha YN, Bertilsson L. Roh HK, et al. Pharmacogenetics. 1996 Oct;6(5):441-7. doi: 10.1097/00008571-199610000-00008. Pharmacogenetics. 1996. PMID: 8946476

5

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.

Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L, Ingelman-Sundberg M. Sim SC, et al. Clin Pharmacol Ther. 2006 Jan;79(1):103-13. doi: 10.1016/j.clpt.2005.10.002. Clin Pharmacol Ther. 2006. PMID: 16413245

6

Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.

Jiang Z, Dragin N, Jorge-Nebert LF, Martin MV, Guengerich FP, Aklillu E, Ingelman-Sundberg M, Hammons GJ, Lyn-Cook BD, Kadlubar FF, Saldana SN, Sorter M, Vinks AA, Nassr N, von Richter O, Jin L, Nebert DW. Jiang Z, et al. Pharmacogenet Genomics. 2006 May;16(5):359-67. doi: 10.1097/01.fpc.0000204994.99429.46. Pharmacogenet Genomics. 2006. PMID: 16609368

7

CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking.

Ramsjö M, Aklillu E, Bohman L, Ingelman-Sundberg M, Roh HK, Bertilsson L. Ramsjö M, et al. Eur J Clin Pharmacol. 2010 Sep;66(9):871-7. doi: 10.1007/s00228-010-0835-0. Epub 2010 May 25. Eur J Clin Pharmacol. 2010. PMID: 20499227 Free article.

8

Quinidine inhibition of debrisoquine S(+)-4- and 7-hydroxylations in Chinese of different CYP2D6 genotypes.

Bertilsson L, Meese CO, Yue QY, Dahl ML, Ingelman-Sundberg M, Johansson I, Säwe J, Eichelbaum M. Bertilsson L, et al. Pharmacogenetics. 1993 Apr;3(2):94-100. doi: 10.1097/00008571-199304000-00005. Pharmacogenetics. 1993. PMID: 8100167

9

Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype.

Wennerholm A, Johansson I, Massele AY, Lande M, Alm C, Aden-Abdi Y, Dahl ML, Ingelman-Sundberg M, Bertilsson L, Gustafsson LL. Wennerholm A, et al. Pharmacogenetics. 1999 Dec;9(6):707-14. Pharmacogenetics. 1999. PMID: 10634133

10

Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe.

Masimirembwa C, Bertilsson L, Johansson I, Hasler JA, Ingelman-Sundberg M. Masimirembwa C, et al. Clin Pharmacol Ther. 1995 Jun;57(6):656-61. doi: 10.1016/0009-9236(95)90228-7. Clin Pharmacol Ther. 1995. PMID: 7781265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters